FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1801-1803 November 28, 2002 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Halpern, S. D. PubMed Citation

To the Editor: Halpern et al. (July 25 issue)¹ provided a compelling ethical rationale for pursuing transplantation in patients infected with the human immunodeficiency virus (HIV). Unfortunately, I believe they missed the point about why patients with HIV infection do not routinely undergo transplantation. We do not know how to do it. What immunosuppressive therapy should be used? What are the interactions of the immunosuppressive agents with the antiviral agents? What effect will immunosuppression have on the activity of HIV?

Rather than have 100 kidney centers each invent the wheel, several large centers with active involvement of infectious-disease specialists should . . . [Full Text of this Article]

This article has been cited by other articles:

• Spano, J.-P., Costagliola, D., Katlama, C., Mounier, N., Oksenhendler, E., Khayat, D. (2008). AIDS-Related Malignancies: State of the Art and Therapeutic Challenges. JCO 26: 4834-4842 [Abstract] [Full Text]